Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 27, 2012

View Archived Issues

Liposomal irinotecan shows benefit in metastatic colorectal cancer

Risk loci for multiple myeloma identified

Phase IIa trial assesses daclatasvir/asunaprevir in difficult-to-treat hepatitis C

BioLineRx signs license agreement with Genoscience

Cephalon scientists disclose synthesis, pharmacological and first clinical data on CEP-11981

Novel polypeptides prepared by Zealand Pharma

Novel phosphodiesterase 10A inhibitors synthesized in Japan

New phosphodiesterase 4 inhibitors presented by Leo Pharma

Abbott profiles pipeline progress of 2011

German team patents new agents with neurogenic and neurotrophic properties

Recruitment begins in phase Ib/II U3-1287 combination study

Vertex Pharmaceuticals patents new serine/threonine-protein kinase ATR inhibitors

Merck & Co. designs new protein kinase inhibitors

RPCI launches first-ever trial of dendritic vaccine plus rapamycin

Celgene announces merger agreement

EMA grants orphan drug status to Celator product

Biogen Idec and Elan evaluate Tysabri in secondary progressive MS

Auxilium Pharmaceuticals doses first patients in Xiaflex study

Studies detail beta-amyloid detection with florbetapir F 18 PET

Kancera subsidiary and Agios Pharmaceuticals launch alliance

Lpath suspends dosing in clinical studies of iSONEP

BioAlliance Pharma outlines major achievements of 2011 and prospects for 2012

Enrollment begins in Japan in phase III trials of orteronel

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...